A lung cancer patient has become the first in the UK to receive a new experimental vaccine to help his body fight the disease.Janusz Racz, 67, had six syringes of the jab, each containing genetic material for a different part of the tumour, to train five billion cells in his immune system to go on the attack. The vaccine, codenamed BNT116, is made by BioNTech using the same mRNA technology that underpinned its highly effective COVID jab.Doctors say it is far more precisely targeted than chemotherapy so shou ...